Granules India Limited to Consider Q2 FY27 Results on November 2

Granules India Limited will consider unaudited Q2 and first-half FY27 results for the period ended September 30, 2026, at its November 2 board meeting, following Q1 revenue of ₹1,477 crore and net profit of ₹180 crore. The results will provide the next reported update on the pharmaceutical company's sales growth and profitability.

When will Granules India Limited announce Q2 FY27 results?

Granules India Limited's Board of Directors is scheduled to meet on Monday, November 2, 2026, to consider and approve the unaudited financial results for the second quarter and half-year ended September 30, 2026. The company disclosed the board-meeting schedule to BSE on October 23 under Regulation 30 of the Listing Obligations and Disclosure Requirements Regulations.

The announcement is a scheduled corporate disclosure rather than a statement of the quarter's financial outcome. The company had not filed the Q2 FY27 figures at the time of the notice. Investors will therefore await the board-approved results for reported revenue, operating performance, net profit and any business updates for the July-September period.

Granules India Limited has also scheduled its Q2 and H1 FY27 earnings conference call for 6:00 PM IST on November 2. The call is intended to cover the financial results and business updates, allowing shareholders and market participants to hear management's discussion after the results are considered.

What did Granules India Limited report in Q1 FY27?

Granules India Limited reported ₹1,477 crore of revenue and ₹180 crore of net profit for the quarter ended June 2026, according to the quarterly data provided ahead of the Q2 announcement. Revenue was 0.4% higher sequentially from ₹1,471 crore in March 2026 and 22.0% higher year on year.

Net profit of ₹180 crore was lower than ₹202 crore in the preceding March 2026 quarter, but was 59.8% above the corresponding prior-year period. Operating profit stood at ₹259 crore, compared with ₹270 crore in March 2026. The operating profit margin was 17.6%, down from 18.4% in the immediately preceding quarter.

The reported figures show that the company entered the September quarter after a period of rising revenue. Quarterly revenue increased from ₹1,297 crore in September 2025 to ₹1,388 crore in December 2025, ₹1,471 crore in March 2026 and ₹1,477 crore in June 2026. However, the Q2 result will determine whether this trajectory continued during the next quarter.

Why is the November 2 board meeting important for investors?

The November 2 meeting is important because it will approve Granules India Limited's first reported financial update after the June quarter. The Q2 result will cover both the July-September quarter and the first six months of FY27, giving investors a fuller view of reported sales and profit performance in the financial year to date.

The June-quarter data showed a difference between top-line and margin trends. Revenue reached ₹1,477 crore, while operating profit fell sequentially to ₹259 crore and operating margin declined by 0.8 percentage points from the March-quarter level. The forthcoming disclosure will show whether these movements persisted, reversed or changed further during Q2.

The company has not disclosed Q2 revenue, profit or margin figures in the board-meeting notice. As a result, the announcement itself does not provide a basis for estimating the quarter's performance. The relevant confirmed information will be contained in the unaudited financial statements approved by the board.

What is Granules India Limited's recent financial background?

Granules India Limited's FY26 financial results provide a longer-term reference point for the upcoming half-year disclosure. For FY26, the company reported standalone revenue of ₹3,523.76 crore and standalone profit after tax of ₹400.67 crore. Consolidated revenue was ₹5,385.97 crore and consolidated profit after tax was ₹595.02 crore.

The board had also recommended a final dividend of ₹1.75 per share with the FY26 results. These annual figures distinguish between the company's standalone operations and consolidated financial performance, while the supplied recent quarterly dataset reports revenue and profits for the quarters leading into Q2 FY27.

Granules India Limited followed a similar quarterly reporting sequence for Q1 FY27. It had informed BSE on July 9, 2026, about the board meeting held on July 21 to consider the June-quarter unaudited results. The November meeting continues that periodic reporting process for the September quarter and first half.

How does the trading-window closure affect Granules India Limited shareholders?

Granules India Limited has kept its insider-trading window closed in connection with the Q2 and half-year results, in line with the company's stated SEBI-compliance process. The company said the window was closed from October 1, 2026, and will reopen 48 hours after the declaration of the unaudited results. Its board-meeting communication also stated that the closure would continue until November 4, 2026.

The restriction applies to designated persons who may have access to unpublished price-sensitive information. It does not alter the financial results or require any action from ordinary shareholders. For investors, the key dates are the board meeting and expected result disclosure on November 2, followed by the earnings call at 6:00 PM IST.

Market participants will focus on the company-reported Q2 numbers when released, including revenue, operating profit, operating margin, net profit and management's business update. Until those filings are available, the June-quarter performance remains the latest reported financial reference in the information provided.

Conclusion

Granules India Limited's November 2 board meeting will determine the formal release of Q2 and H1 FY27 unaudited results. The company enters the announcement after reporting ₹1,477 crore revenue and ₹180 crore net profit in Q1 FY27, with revenue growth remaining positive but operating profit and margin below the March-quarter levels.

Investors will next watch for the board-approved Q2 and half-year financial statements and management's comments during the 6:00 PM IST earnings call on November 2. The insider-trading window is stated to remain closed until November 4, 2026, or reopen 48 hours after the result declaration.